stockgist
HomeTop MoversCompaniesConcepts

Market

  • Top Movers
  • Companies
  • Concepts

SEC Filings

  • AI Filing Analysis
  • Financial Reports
  • Current Reports
  • IPO Filings

Ownership

  • Institutional Holdings
  • Insider Trading

About

  • Data updates every 5 min
  • SEC EDGAR Source
© 2025–2026 StockGist|Information only, not investment advice
    1. Companies
    2. DHR
    stockgist
    HomeTop MoversCompaniesConcepts
    DHR logo

    Danaher Corporation

    DHR
    NYSE
    Healthcare
    Medical - Diagnostics & Research
    Washington, DC, US61,000 employeesdanaher.com
    $191.02
    +0.23(0.12%)

    Mkt Cap $135.1B

    $174.64
    $242.05

    52-Week Range

    At a Glance

    AI-generated

    Revenue breakdown: Diagnostics Segment (40.5%), Life Sciences Segment (30.1%), Biotechnology Segment (29.3%).

    8-K
    Danaher Corporation announced entry into a definitive Merger Agreement dated February 16, 2026, to acquire all outstanding shares of Masimo Corporation for $180 per share in cash, representing an enterprise value of approximately $9.9 billion. The transaction is subject to customary conditions including regulatory approvals and Masimo shareholder approval, with closing anticipated in the second half of 2026.

    $135.1B

    Market Cap

    $24.6B

    Revenue

    $3.6B

    Net Income

    Employees61,000
    Fundamentals

    How The Business Makes Money

    Revenue by Segment

    Diagnostics Segment40.5%($87.9B)
    Life Sciences Segment30.1%($65.4B)
    Biotechnology Segment29.3%($63.7B)

    Revenue by Geography

    North America28.2%($61.2B)
    High Growth Markets19.4%($42.2B)
    All Other Countries15.8%($34.3B)
    Western Europe15.5%($33.7B)
    US13.6%($29.5B)
    CN4%($8.6B)
    Other Developed Markets3.5%($7.5B)
    Activity

    What Changed Recently

    Management Change
    Feb 9, 2026

    DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS On February 5,

    Financial Results
    Jan 27, 2026

    of Form 8-K. This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or

    Financial Results
    Jan 11, 2026

    of Form 8-K such press release as well as the presentation slides attached hereto, each of which is incorporated by reference herein. The presentation slides at

    Other Event
    Feb 16, 2026

    . Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.” and which

    Peer Companies

    CompanyPriceChangeMarket CapP/E
    AMGNAmgen Inc.$347.93-1.51%$187.6B24.4
    TMOThermo Fisher Scientific ...$492.92-0.33%$183.1B26.8
    GILDGilead Sciences, Inc.$139.63-0.48%$173.3B20.0
    PFEPfizer Inc.$28.36-0.65%$161.3B19.6
    ISRGIntuitive Surgical, Inc.$452.40-2.59%$160.7B59.4
    SYKStryker Corporation$331.73+0.71%$126.9B39.2
    SNYSanofi$47.91+0.39%$116.7B8.9
    MDTMedtronic plc$86.63+0.66%$111.2B24.2
    Analyst View
    Company Profile
    CIK0000313616
    ISINUS2358511028
    CUSIP235851102
    Phone202 828 0850
    Address2200 Pennsylvania Avenue, NW, Washington, DC, 20037-1701, US
    SEC EDGAR

    Market

    • Top Movers
    • Companies
    • Concepts

    SEC Filings

    • AI Filing Analysis
    • Financial Reports
    • Current Reports
    • IPO Filings

    Ownership

    • Institutional Holdings
    • Insider Trading

    About

    • Data updates every 5 min
    • SEC EDGAR Source
    © 2025–2026 StockGist|Information only, not investment advice